SIRENS for Elder Abuse and Dementia
(SIRENS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop a new tool and support program to help doctors identify signs of neglect in older adults with dementia. It will test a technology-based intervention called SIRENS, designed for caregivers, offering expert-reviewed information and resources to support their caregiving. The trial will compare the effectiveness of the screening tool alone and with the support program against standard care. Primary caregivers who provide at least 8 hours of care per week to older adults with dementia are good candidates for this trial.
As an unphased trial, participants can contribute to groundbreaking research that may improve caregiving for dementia patients.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this screening tool and support program are safe for older adults with dementia?
Research shows that the SIRENS program, which supports caregivers of people with dementia, provides helpful information and resources. No specific data indicates any safety issues or negative effects from this program. As a technology-based tool, it is unlikely to cause physical harm.
Programs like SIRENS often help caregivers better manage their loved ones' needs, reducing stress and leading to better outcomes. In other studies of similar support programs, caregivers reported feeling more capable and less stressed. This suggests that the SIRENS program could also be safe and helpful.12345Why are researchers excited about this trial?
The SIRENS intervention is unique because it offers caregivers of those with dementia a technology-based tool that combines expert-reviewed information with practical resources. Unlike traditional support groups or educational sessions, SIRENS provides take-home messages that summarize key points and a goal-setting feature that encourages caregivers to establish small, actionable goals. Researchers are excited because this approach empowers caregivers with tailored support and the flexibility to access help at their convenience, potentially improving both caregiver well-being and patient care outcomes.
What evidence suggests that the SIRENS intervention is effective for elder abuse and dementia?
Research has shown that older adults with dementia are more likely to experience elder abuse, which often goes unnoticed or unreported. In this trial, the SIRENS program aims to tackle this issue by providing caregivers with easy access to expert-reviewed information and resources through a mobile app. Although one study found no significant change in abuse scores with similar programs, SIRENS focuses on improving support and education for caregivers. This approach might lead to better outcomes by helping caregivers set small, practical goals, potentially reducing neglect. Overall, the goal is to empower caregivers and enhance their ability to care for people with dementia effectively.678910
Who Is on the Research Team?
Sara J Czaja, PhD
Principal Investigator
Weill Cornell Medical College of Cornell University
Anthony Rosen, MD
Principal Investigator
Weill Cornell Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for older adults showing signs of neglect with dementia. Participants must be able to visit the doctor for screening and use an Android phone if they're in the group that gets the support program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the SIRENS technology-based intervention designed for caregivers of those with dementia
Follow-up
Participants are monitored for system feasibility, acceptability, and usability, as well as caregiving self-efficacy, depression, burden, quality of life, and preparedness
What Are the Treatments Tested in This Trial?
Interventions
- SIRENS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator